跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK 10 mg+20 mg ezetimibe 10 mg tablet and rosuvastatin (as calcium) 20 mg tablet blister composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK 10 mg+20 mg ezetimibe 10 mg tablet and rosuvastatin (as calcium) 20 mg tablet blister composite pack
Approved
STANDARD
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK 10 mg+20 mg ezetimibe 10 mg tablet and rosuvastatin (as calcium) 20 mg tablet blister composite pack
Pharmacor Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
f2184b8395e2c0c6
Company
Pharmacor Pty Ltd
Type
Standard
Approval Details
Approval Id
f2184b8395e2c0c6
Product Name
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK 10 mg+20 mg ezetimibe 10 mg tablet and rosuvastatin (as calcium) 20 mg tablet blister composite pack
Artg Id
375663
Artg Name
PHARMACOR EZETIMIBE ROSUVASTATIN COMPOSITE PACK 10 mg+20 mg ezetimibe 10 mg tablet and rosuvastatin (as calcium) 20 mg tablet blister composite pack
Sponsor
Pharmacor Pty Ltd
Company Detail Path
/organization/pharmacor-sa-pty-ltd
Artg Date
2023-02-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01229-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-01230-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
f2184b8395e2c0c6
Type
Standard
Back to TGA Approvals